ICPT Stock Summary

• ICPT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 660.7 -- higher than 93.53% of US-listed equities with positive expected earnings growth.
• With a price/sales ratio of 15.8, Intercept Pharmaceuticals Inc has a higher such ratio than 92.51% of stocks in our set.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 9.64 for Intercept Pharmaceuticals Inc; that's greater than it is for 92.12% of US stocks.
• If you're looking for stocks that are quantitatively similar to Intercept Pharmaceuticals Inc, a group of peers worth examining would be MRAM, CERS, PACB, PLUG, and NSTG.
• Visit ICPT's SEC page to see the company's official filings. To visit the company's web site, go to www.interceptpharma.com.